The Latest

  • A close up of the Eargo 6 hearing device.
    Image attribution tooltip
    Permission granted by Eargo
    Image attribution tooltip

    Eargo, Hearx merge into one OTC hearing aid firm, receive $100M boost

    Hearx, the maker of Lexie hearing aids, and Eargo competed for the OTC hearing aid market that the FDA created in 2022.

  • Red human heart drawing on blue background
    Image attribution tooltip
    Jolygon via Getty Images
    Image attribution tooltip

    3 takeaways from ACC 2025

    Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.

  • A line of people stand outside the Switzer Memorial Building in Washington, D.C.
    Image attribution tooltip
    Kevin Dietsch/Getty Images via Getty Images
    Image attribution tooltip
    HHS overhaul

    HHS layoffs characterized by confusion, errors

    The sweeping workforce reduction that began Tuesday was made worse by mistakes and poor communication, including directions for some CMS employees to contact a director who died last year.

    Updated April 2, 2025
    FDA
  • A picture of a researcher standing in front of a testing machine in a laboratory.
    Image attribution tooltip
    Karen Ducey/Getty Images via Getty Images
    Image attribution tooltip

    Texas judge overturns FDA’s lab developed test regulation, siding with industry groups

    The judge vacated the FDA’s final rule, which was strongly opposed by the laboratory industry, and remanded the matter to HHS Secretary Robert F. Kennedy Jr.

  • Front sign of FDA building
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip
    HHS overhaul

    HHS layoffs could imperil medical device cybersecurity, Democrats say

    The FDA has 3,500 jobs on the chopping block, which could hinder cybersecurity oversight, Democrats said during a House subcommittee hearing.

    FDA
  • An older women's eye is seen up close.
    Image attribution tooltip
    Alexander Ford via Getty Images
    Image attribution tooltip

    Bausch + Lomb recalls Envista intraocular lenses over safety risks

    J.P. Morgan analysts said it was too early to discuss the financial impact of the recall, but estimated that $70 million to $90 million of revenue could be at risk this year.

  • Robert F. Kennedy Jr. stands in front of croded congressional room
    Image attribution tooltip
    Win McNamee via Getty Images
    Image attribution tooltip
    HHS overhaul

    HHS begins layoffs in chaotic fashion

    The Trump administration sent out the first round of reduction-in-force notices early Tuesday morning, telling employees the cuts are necessary to improve efficiency.

    FDA
  • RFK Jr. strides down a Capitol Hill hallway thronged by aides and reporters.
    Image attribution tooltip
    Anna Moneymaker via Getty Images
    Image attribution tooltip
    HHS overhaul

    ‘Everything is word of mouth’: HHS employees face uncertainty in looming Trump layoffs

    Many HHS department heads and employees were unaware of plans to fire some 10,000 employees until they were announced Thursday, sources said.

  • A flat hand holds up an at-home STI test against a white bakcground
    Image attribution tooltip
    Courtesy of Visby Medical
    Image attribution tooltip

    FDA OKs first at-home test for 3 STIs

    Visby Medical’s at-home diagnostic, which can be purchased without a prescription, tests for chlamydia, gonorrhea and trichomoniasis.

    FDA
  • A photo of FDA CBER Director Peter Marks delivering remarks at a public workshop on March 3, 2020.
    Image attribution tooltip
    Ermath, Michael. (2020). "Individualized Therapies Workshop" [Photograph]. Retrieved from Flickr.
    Image attribution tooltip

    Peter Marks, FDA’s top vaccine official, resigns

    In his resignation letter, Marks cited disagreement with HHS Secretary Robert F. Kennedy Jr., who he said pushed “misinformation and lies.”

    FDA
  • Professional photo of Jordan Pinsker
    Image attribution tooltip
    Permission granted by Tandem Diabetes Care
    Image attribution tooltip

    Tandem eyes Medicare coverage expansion for Type 2

    CMO Jordan Pinsker said Tandem hopes to expand Medicare coverage of its automated insulin delivery systems using new data shared at ATTD.